8-chloro-6-(2-chlorophenyl)-1-(hydroxymethyl)-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-ol (65686-12-6)

Identification
Name:	8-chloro-6-(2-chlorophenyl)-1-(hydroxymethyl)-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-ol
Synonyms:	LogP
CAS:	65686-12-6
Molecular Formula:	C₁₇H₁₂Cl₂N₄O₂
Molecular Weight:	375.2088
InChI:	InChI=1/C17H12Cl2N4O2/c18-9-5-6-13-11(7-9)15(10-3-1-2-4-12(10)19)20-17(25)16-22-21-14(8-24)23(13)16/h1-7,17,24-25H,8H2
Molecular Structure:
Properties
Flash Point:	335.914°C
Boiling Point:	631.822°C at 760 mmHg
Density:	1.629g/cm³
Refractive index:	1.76
Flash Point:	335.914°C
Safety Data

Other Product

b-D-Glucopyranosiduronic acid,8-chloro-6-(2-chlorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl(9CI)
4H-[1,2,4]Triazolo[4,3-a][1,4]benzodiazepin-4-ol,8-chloro-1-methyl-6-phenyl-
8-chloro-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-ol
2-(8-chloro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-1-yl)-N,N-dimethylethanamine 4-methylbenzenesulfonate (1:1)
4H-Imidazo[1,5-a][1,4]benzodiazepin-4-ol,8-chloro-6-(2-fluorophenyl)-1-methyl-
4H-[1,2,4]Triazolo[4,3-a][1,4]benzodiazepine,8-chloro-6-(2-chlorophenyl)-1-[[(4-methylphenyl)thio]methyl]-
Methanesulfonamide,N-[[8-chloro-6-(2-chlorophenyl)-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-1-yl]methyl]-
4H-(1,2,4)Triazolo(4,3-a)(1,4)benzodiazepine, 8-chloro-6-(2-chlorophenyl)-1-(4-methyl-1-piperazinyl)-, ethanedioate (1:1)
4H-(1,2,4)Triazolo(4,3-a)(1,4)benzodiazepine, 8-chloro-6-(2-chlorophenyl)-1-(4-(3-methoxypropyl)-1-piperazinyl)-, (E)-2-buteneioate (1:1)
Ethanamine,2-[[[8-chloro-6-(2-chlorophenyl)-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-1-yl]methyl]thio]-N,N-dimethyl-
4H-[1,2,4]Triazolo[4,3-a][1,4]benzodiazepine,8-chloro-6-(2-chlorophenyl)-1-(4-methyl-1H-imidazol-5-yl)-
4H-(1,2,4)Triazolo(4,3-a)(1,4)benzodiazepine, 8-chloro-6-(2-chlorophen yl)-1-(((4-chlorophenyl)thio)methyl)-
4H-(1,2,4)Triazolo(4,3-a)(1,4)benzodiazepine, 8-chloro-6-(2-chlorophenyl)-1-((4-(2-methoxyethyl)-1-piperazinyl)methyl)-, (E)-2-butenedioate (2:3)
4H-(1,2,4)Triazolo(4,3-a)(1,4)benzodiazepine, 8-chloro-6-(2-chlorophenyl)-1-((4-methyl-1-piperazinyl)methyl)-, (E)-2-butenedioate (2:3)
8-Bromo-6-(2-chlorophenyl)-1-(5-methyl-4-imidazolyl)-4H-s-triazolo(4,3-a)-1,4-benzodiazepine
Methanesulfonamide,N-[[8-bromo-6-(2-chlorophenyl)-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-1-yl]methyl]-
Phenol,4-(8-chloro-1-methyl-4H-imidazo[1,- 5-a][1,4]benzodiazepin-6-yl)-3-fluoro-
4H-(1,2,4)Triazolo(4,3-a)(1,4)benzodiazepine, 8-chloro-6-(2-chlorophenyl)-1-(4-(2-(methylthio)ethyl)-1-piperazinyl)-, (R-(R*,R*))-2,3-dihydroxybutanedioate (1:1)
4H-(1,2,4)Triazolo(4,3-a)(1,4)benzodiazepine, 8-chloro-6-(2-chlorophenyl)-1-(4-(2-methoxyethyl)-1-piperazinyl)-, (E)-2-butenedioate (1:2)
4H-(1,2,4)Triazolo(4,3-a)(1,4)benzodiazepine, 8-chloro-6-(2-chlorophenyl)-1-(4-(2-(methylthio)ethyl)-1-piperazinyl)-, ethanedioate, hydrate (2:2:1)